Global Antibiotic R&D Partnership (GARDP)

2024 in Review: AMR Community Stock-Take Join GARDP and AMR-CC for an insightful webinar reflecting on the progress made, the challenges faced, and the path forward in tackling antimicrobial resistance. 📅 9 December, 2024 🕘 09:00 ET | 14:00 UTC | 15:00 CET Register now: https://lnkd.in/dvRqPbAG #AMR #PowerOfAntibiotics #Webinar United Nations Foundation

Exciting news for REVIVE! We recently gathered a fantastic group of stakeholders to share their feedback with us. This meeting yielded exciting ideas some of which are now being further developed by us. Watch this space! We're committed to advancing antimicrobial R&D through collaboration and your input is valuable. Have any ideas for REVIVE? Don’t hesitate to get in touch at [email protected]. Thanks again to all who took part in our advisory meeting: Michael Corley, Olga Genilloud, Laura Hollis, Samuel Kraus, Jimmy Nkaiwuatei, Marnie Peterson, PharmD PhD, Vasan Sambandamurthy, Kamini Walia, and our chair Mark Blaskovich. #AMR #AntimicrobialResistance #DrugDiscovery #Antibiotics

On December 5, Carol Ruffell (she/her), DNDi GARDP Southern Africa Director, participated in Pfizer’s AMR Roundtable at the International Congress on Infectious Diseases 2024. Ruffell joined the "Solution Summit" panel on AMR gaps in current/newer generation antibiotics, the panel highlighted critical issues like: • Regulation, legislation, and policy frameworks • Access, affordability, and stewardship balance • Shelf stability and administration in resource-constrained settings • Quality and pharmacovigilance • R&D opportunities on the African continent This dialogue is key to addressing Africa's unique AMR challenges and driving innovation for sustainable solutions. International Society for Infectious Diseases #AMR #ICID2024 #PfizerAMRRoundtable #ISID

GARDP’s Executive Director, Dr Manica Balasegaram accepted an award for the Breakthroughs category at the Fierce 50 Awards Gala in New York. The Fierce 50 is a groundbreaking award that highlights the people & companies driving meaningful change in healthcare, pharma and biotech. During the gala’s panel discussion, Dr Balasegaram highlighted the growing threat of #AntimicrobialResistance, and showcased GARDP’s partnership with Innoviva Specialty Therapeutics, Inc. as a novel model for drug discovery and development that is crucial for addressing the global AMR crisis. “This groundbreaking antibiotic research & development partnership model paves the way for the development of other antibiotics to address the impact of antimicrobial resistance (AMR),” said Dr Balasegaram. #Fierce50 #PowerOfAntibiotics

Reflect. Review. Act. Join GARDP and AMR-CC for an insightful webinar on "2024 in Review: AMR Community Stock-Take". We'll discuss progress in tackling #AMR and chart the way forward. 📅 9 December 2024 🕘 9:00-10:00 ET | 15:00-16:00 CET Register now: https://lnkd.in/dvRqPbAG

What is implementation research, and how does it help ensure appropriate use of and access to drugs? In this video, Fernando Pascual Martinez, GARDP’s Access Development Lead, explains. Interested in learning more about what implementation research can do for #antibiotics? Join Fernando as he moderates the next REVIVE webinar on this topic with a panel of speakers: 💡 Joy Lawn 💡 Malabika Sarker 💡 Christine Halleux 📅 3 December 5 pm CET 👉 Register now: https://lnkd.in/drhH7Cpp #AMR #GlobalHealth #ImplementationResearch #Antimicrobials #AntimicrobialResistance #WAAW2024

This World Aids Day, we shine the spotlight on South Africa. The country can be considered an HIV success story where HIV infections are down 57%, while deaths due to AIDS have plummeted by 70% since 2010. But future progress is in jeopardy. “Antimicrobial resistance is one of the absolute top things that could set back progress in HIV patients. I mean, we have the HIV drugs now—that’s not the limiting factor. One of the things that might make things go backwards is AMR,” says Dr Jeremy Nel, Head of Infectious Diseases at the Helen Joseph Hospital in Johannesburg. The #WorldAidsDay2024 theme “Take the Rights Path: My Health, My Right” is a call to ensure equitable access to lifesaving treatments everywhere. 👉Read Jeremy’s story: https://lnkd.in/dsNjevBQ #AMR #PowerOfAntibiotics #WorldAidsDay2024

Recently our Associate Director for Medical Sciences, Alison Luckey participated in the Shionogi Europe scientific symposium on "Global Best Practices and Chances for Germany" “Antibiotic resistance claims 4.95 million lives every year. Our ability to treat infections and safeguard modern healthcare advances is at stake. GARDP is committed to ensuring a future where antibiotics remain accessible and effective.” Alison Luckey FFPM Read more about the event: https://lnkd.in/dxQQZ-Ca #AMR #AntibioticResistance #ScientificSymposium

Researchers and site teams in South Africa and India have gathered in Cape Town and New Delhi respectively, to discuss the initial results of GARDP’s observational study on the management of antibiotic-resistant infections in hospitals. Data was collected and analyzed from patients being treated for infections caused by carbapenem-resistant organisms across five hospitals in India and five hospitals in South Africa. We are very grateful to our excellent site teams in both countries. The information gleaned from the study could ultimately help to improve treatments for hospital-acquired infections, which are among the deadliest of antibiotic-resistant infections. Indian Council of Medical Research (ICMR) Carol Ruffell (she/her) Francois Franceschi #AMR #PowerOfAntibiotics #ResearchAndDevelopment #India #SouthAfrica

GARDP’s Executive Director, Dr Manica Balasegaram, recently spoke to The Economic Times about a double challenge driving antimicrobial resistance (AMR). "AMR has been haunted by a spectre of market and public health failure," he told the publication. A decline in research and development for new treatments has left the global community vulnerable. However, economies like India, with a strong track record in production and supply, offer critical opportunities to accelerate innovation and improve access. Listen: https://lnkd.in/dKg-UHAR #AMR #AntimicrobialResistance #Access #PowerOfAntibiotics